Patents by Inventor Catherine Turkel

Catherine Turkel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10149893
    Abstract: Methods for modifying progression of osteoarthritis by local administration of a clostridial derivative, such as a botulinum toxin, to an arthritis-affected site are disclosed herein.
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: December 11, 2018
    Assignee: Allergan, Inc.
    Inventors: Guang L. Jiang, Catherine Turkel
  • Publication number: 20150086531
    Abstract: Methods for modifying progression of osteoarthritis by local administration of a clostridial derivative, such as a botulinum toxin, to an arthritis-affected site are disclosed herein.
    Type: Application
    Filed: September 24, 2013
    Publication date: March 26, 2015
    Applicant: Allergan, Inc.
    Inventors: Guang-Liang Jiang, Catherine Turkel
  • Publication number: 20060121057
    Abstract: The present invention features methods for selecting a patient with an enhanced therapeutic response to a botulinum toxin treatment of a headache. In some embodiments, the methods comprise the step of identifying a patient who is not using a prophylactic headache pain medication, a patient who is overusing an acute pain medication, a patient who suffers four or more hours of headache pain per headache, a patient who has a chronic daily headache for twenty or more years, and/or a patient who has twenty or more headache days out of a 30-day-month.
    Type: Application
    Filed: January 11, 2006
    Publication date: June 8, 2006
    Applicant: ALLERGAN, INC.
    Inventors: Catherine Turkel, Mitchell Brin
  • Publication number: 20060104995
    Abstract: The present invention features a method for treating a headache in an acute pain medication overuse patient. In some embodiments, the method comprises the step of local administration of a botulinum toxin to a patient who is an acute pain medication overuse patient, thereby both countering a headache exacerbation caused by the acute pain medication overuse and reducing the use of the acute pain medication by the patient to treat a headache.
    Type: Application
    Filed: December 28, 2005
    Publication date: May 18, 2006
    Applicant: ALLERGAN, INC.
    Inventors: Catherine Turkel, Mitchell Brin
  • Publication number: 20050191321
    Abstract: A headache can be treated more effectively by co-administration of a botulinum toxin and a triptan drug to a patient and/or the effectiveness of a triptan medication can be increased. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of where a patient experiences or is predisposed to experience pain or a headache.
    Type: Application
    Filed: January 18, 2005
    Publication date: September 1, 2005
    Applicant: ALLERGAN, INC.
    Inventors: Catherine Turkel, Mitchell Brin
  • Publication number: 20050191320
    Abstract: An acute pain medication overuse disorder (such as a medication overuse headache disorder) can be treated by administration of a botulinum toxin to a patient. The botulinum toxin can be botulinum toxin type A and the botulinum toxin can be administered to or to the vicinity of where a patient experiences or is predisposed to experience pain or a headache.
    Type: Application
    Filed: February 26, 2004
    Publication date: September 1, 2005
    Inventors: Catherine Turkel, Mitchell Brin